The all-cash deal will bolster the pharmaceutical company’s core immunology franchise.
Source link
About The Author
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion
The all-cash deal will bolster the pharmaceutical company’s core immunology franchise.
Source link